| PERIOD ENDING | 31-Oct-08 | 31-Oct-07 | 31-Oct-06 | | Total Revenue | 22,338,579 | 27,690,211 | 20,060,689 | | Cost of Revenue | 10,039,616 | 11,368,630 | 7,663,965 | | | Gross Profit | 12,298,964 | 16,321,581 | 12,396,724 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 6,038,170 | 7,346,126 | 5,780,319 | | Non Recurring | 6,621 |
-
|
-
| | Others | 830,910 | 282,906 | 192,737 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 5,423,263 | 8,692,549 | 6,423,668 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 19,035 | (46,103) | 8,031 | | Earnings Before Interest And Taxes | 5,442,298 | 8,710,361 | 6,454,898 | | Interest Expense | 2,160,864 | 3,234,559 | 2,395,826 | | Income Before Tax | 3,281,434 | 5,475,803 | 4,059,073 | | Income Tax Expense | 571,872 | 1,080,282 | 775,409 | | Minority Interest | (98,484) | (123,640) | (87,445) | | | | Net Income From Continuing Ops | 2,611,078 | 4,207,965 | 3,173,019 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 2,611,078 | 4,207,965 | 3,173,019 | | Preferred Stock And Other Adjustments | (88,553) | (53,438) | (26,769) | | | Net Income Applicable To Common Shares | $2,522,525 | $4,154,527 | $3,146,250 |
|
0.28% Nasdaq 0.00%
Income Statement
